Yahoo! Finance: Top Stories

Travere Therapeutics Rallies To Buy Point As Kidney Drug Sales Rocket 182%; Anticipates FDA Priority Review For FSGS Treatment

May 6, 2025 - 17:34
 0
Travere Therapeutics Rallies To Buy Point As Kidney Drug Sales Rocket 182%; Anticipates FDA Priority Review For FSGS Treatment
Read More

Tags:

Previous Article

'Major Economic Disaster' Amid Trump Tariffs: American Small Business Owners Fac...

Next Article

Supio Raises $60M Series B With Backing From Thomson Reuters Ventures, Sapphire ...

Related Posts

Jim Cramer Favors Vulcan and Martin Marietta Over CRH plc (CRH)

Jim Cramer Favors Vulcan and Martin Marietta Over CRH p...

Apr 27, 2025  0

Buc-ee’s lawsuit forces Barc-ee’s shutdown

Buc-ee’s lawsuit forces Barc-ee’s shutdown

Apr 30, 2025  0

Google is fighting a new DOJ bid to break up another part of its empire

Google is fighting a new DOJ bid to break up another pa...

May 4, 2025  0